Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(29)
•••
Comment by elgin1on Jan 15, 2019 4:49pm
54 Views
Post# 29236273

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:BIOTRUMP

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:BIOTRUMP
Redbaron2211 wrote: Point is if you did in fact sell all your commons from the last PP some time after Nov 14th then why have you been on this board trying to depress the SP since Sept 2018?  See how low you can get the SP to sell your commons?  Like I said your obviously not here to make money or your just really thick in the head.  

I have done my DD on this company and also hold warrants from the last PP.  But unlike you I have not sold my commons and will be waiting for a nice payday rather then bashing the stock to see how low I can possibly sell my shares...  





Redbarron you are correct,  old warrants expired worthless. Sp has not exceeded 25 cents for this since last pp. Bioteck is bashing the company so much why would he invest in it the first place?

Anyways at recent JPM conference Viacycte had no mention of progress of their clinical trail that supposedly started in 2018 instead they focussed on their patent portfolio.

As for Sva, after pouch has been transplanted and shown to be safe after 90 days sentinels will be placed in pouch.  Hopefully results will be released as trial progresses.

Good day to all.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities